|
|
|
|
BRIEF: Teva sues Mylan over birth control drug - report: "Bloomberg" says Teva wants to halt FDA approval for Mylan's versions u
The pills are based on the active ingredients ethinyl estradiol and levonorgestrel.The patent related to LoSeasonique expire in 2023 and the patent tied to Seasonique expires in 2024, and Teva wants to halt FDA approval for Mylan's versions until the...
|
|
|
Teva sues Mylan over birth control drug - report
'Bloomberg' says Teva wants to halt FDA approval for Mylan's versions until the patents expire.Globes' correspondent14 Mar 10 10:29 'Bloomberg' reports that Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) has sued Mylan Inc., which is...
|
|
|
Efficacy of mifepristone in reducing intermenstrual vaginal bleeding in users of the levonorgestrel intrauterine system
Lal S et al.Efficacy of mifepristone in reducing intermenstrual vaginal bleeding in users of the levonorgestrel intrauterine system.
|
|
|
Long-term LNG-IUS use does not affect BMD
MedWire News: Researchers have found that bone mineral density (BMD) is similar between long-term users of the levonorgestrel-releasing intrauterine system (LNG-IUS) and the intrauterine device (IUD), thus refuting concerns over the LNG-IUS effect on BMD....
|
|
|
Sublingual misoprostol does not ease repeat insertion of LNG-IUS
MedWire News: Sublingual misoprostol is not effective for easing insertion of the levonorgestrel-releasing intrauterine system (LNG-IUS) in women having a repeat insertion, show Swedish researchers.Although misoprostol priming of the cervix has been...
|
|
|
[CTU]-Options now eyed in emergency contraception
Options now eyed in emergency contraception Clinicians are familiar with use of dedicated emergency contraceptive (EC) products such as Plan B One-Step (Teva Pharmaceuticals USA) and Next Choice (Watson Pharmaceuticals), as well as the EC use of the copper...
|
|
|
[CTU]-New option available for heavy menstrual bleeding
New option available for heavy menstrual bleeding Flip through your patient files from the last week.If you see heavy menstrual bleeding checked several times in your charts, there's a good reason: One-third of all women report such bleeding at some point...
|
|
|
'Morning After Pill' Works up to 5 Days After Sex
(PhysOrg.com) -- A team of researchers from the United States and Europe has published new evidence supporting the use of ulipristal acetate as an effective alternative to levonorgestrel (marketed as Plan B) for emergency contraception.This study was...
|
|
|
Ulipristal Acetate is Effective for Emergency Contraception
Not a member yet?HealthandAge member? please Or By: June Chen, MD Emergency contraception, sometimes referred to as the morning after pill, is birth control that can be used to prevent pregnancy after unprotected intercourse? The most widely-used...
|
|
|
FRC Statement on New Policy Requiring Military Bases to Carry 'Morning After' Pill
Latest Health News WASHINGTON, Feb.5 /PRNewswire-USNewswire/ -- The Family Research Council today criticized a decision by the Obama Administration to require military bases worldwide to carry Levonorgestrel, or 'Plan B.' (Logo: http://www.newscom.com...
|
|
|
FRC Statement on New Policy Requiring Military Bases to Carry 'Morning After' Pill
WASHINGTON, Feb.5 /PRNewswire-USNewswire/ -- The Family Research Council today criticized a decision by the Obama Administration to require military bases worldwide to carry Levonorgestrel, or 'Plan B.' (Logo: http://www.newscom.com/cgi-bin/prnh...
|
|
|
FRC Statement on New Policy Requiring Military Bases to Carry 'Morning After' Pill
WASHINGTON, Feb.5 /PRNewswire-USNewswire/ -- The Family Research Council today criticized a decision by the Obama Administration to require military bases worldwide to carry Levonorgestrel, or 'Plan B.' (Logo: http://www.newscom.com/cgi-bin/prnh...
|
|
|
FRC Statement on New Policy Requiring Military Bases to Carry 'Morning After' Pill
WASHINGTON (Logo: http://www.newscom.com/cgi-bin/prnh/20080930/FRCLOGO) Jeanne Monahan 'Family Research Council opposes requiring military bases worldwide to carry Levonorgestrel, or 'Plan B,' because the drug can prevent a fertilized embryo from...
|
|
|
Watson and HRA Pharma Announce Exclusive Licensing Agreement to Commercialize Novel Emergency Contraceptive in
- New data published in The Lancet demonstrate effective pregnancy prevention as compared to currently available emergency contraceptive options - MORRISTOWN, N.J., Feb.1 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI) and HRA Pharma...
|
|
|
Watson and HRA Pharma Announce Exclusive Licensing Agreement to Commercialize Novel Emergency Contraceptive in the U.S.
- New data published in The Lancet demonstrate effective pregnancy prevention as compared to currently available emergency contraceptive options - MORRISTOWN, N.J., Feb.1 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) and HRA Pharma...
|
|
|
Watson Files FDA Application for Generic LoSeasonique
- Paragraph IV Litigation Underway - MORRISTOWN, N.J., Jan.8 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI) , a leading specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc., has filed an...
|
|
|
Consecutive use of levonorgestrel-releasing intrauterine system safe and effective
NEW YORK (Reuters Health) - Women who have a popular levonorgestrel-releasing intrauterine device removed after several years can immediately have another one inserted if they wish, according to a report from Finland.'Removal and replacement of the ...
|
